• Software
  • Services
    • Consulting Services
      • Early Drug Discovery
      • Physiologically Based Pharmacokinetics (PBPK)
      • Quantitative Systems Pharmacology (QSP)
      • Clinical Pharmacology & Pharmacometrics (CPP)
      • Adaptive Learning & Insights (ALI)
      • Medical Communications
    • Consulting Packages
      • Consult + Coach
      • First-in-Human Simulator
      • NAMVantage™
      • Pulmonary Package
    • Concierge
    • Regulatory Strategies Center of Excellence
    • Learning Services
  • Events
    • Upcoming Events
    • Webinars
    • Live Workshops
    • On Demand Workshops
    • Scientific Meetings
    • Past Events
  • Resource Center
    • Blog
    • Journal Articles
    • Flyers
    • Posters
    • Presentations
    • Press Releases
    • Videos
    • White Papers
    • Webinars
  • Careers
  • Investors
    • Conference Calls & Presentations
    • Environmental, Social and Governance (ESG)
    • Corporate Profile
    • Board of Directors
    • SEC Filings
    • Press Releases
    • Shareholder Information
    • Corporate Development Initiative
  • About
    • Our Team
    • Leadership
    • Board of Directors
    • Partners and Collaborators
    • Privacy Notice
    • Contact Us
  • Support
    • Customer Portal
    • Datasheets
    • Software Installation
    • Contact Support
  • Search
Simulations Plus logo
Simulations Plus logo

Simulations Plus

We Improve Health Through Innovative Solutions

  • Software
      • GastroPlus®
      • MonolixSuite™
      • ADMET Predictor®
      • DILIsym®
      • DDDPlus™
      • NAFLDsym®
      • MembranePlus™
      • Monolix®
      • OBESITYsym™
      • PKanalix®
      • Simulx®
      • IPFsym®
      • ILDsym®
      • RENAsym®
      • Pro-ficiency
      • Panorama KOL Insights Engine
      • MedChem Designer™
      • Clinical Pharmacology & Pharmacometrics (CPP)
      • Quantitative Systems Pharmacology (QSP)
      • Physiologically Based Pharmacokinetic (PBPK) Software
      • Cheminformatics
      • Adaptive Learning Insights (ALI)
      • Medical Communications
      • Software Packages
        • Consult + Coach
        • Plug ‘n’ Play
        • Pulmonary Package
        • First-in-Human Simulator
        • EvolvePK+
        • Liver Safety+
        • NAMVantage™
      • University+
  • Services
    • Consulting Services
      • Early Drug Discovery
      • Physiologically Based Pharmacokinetics (PBPK)
      • Quantitative Systems Pharmacology (QSP)
      • Clinical Pharmacology & Pharmacometrics (CPP)
      • Adaptive Learning & Insights (ALI)
      • Medical Communications
    • Consulting Packages
      • Consult + Coach
      • First-in-Human Simulator
      • NAMVantage™
      • Pulmonary Package
    • Concierge
    • Regulatory Strategies Center of Excellence
    • Learning Services
  • Events
    • Upcoming Events
    • Webinars
    • Live Workshops
    • On Demand Workshops
    • Scientific Meetings
    • Past Events
  • Resource Center
    • Blog
    • Journal Articles
    • Flyers
    • Posters
    • Presentations
    • Press Releases
    • Videos
    • White Papers
    • Webinars
  • Careers
  • Investors
    • Conference Calls & Presentations
    • Environmental, Social and Governance (ESG)
    • Corporate Profile
    • Board of Directors
    • SEC Filings
    • Press Releases
    • Shareholder Information
    • Corporate Development Initiative
  • About
    • Our Team
    • Leadership
    • Board of Directors
    • Partners and Collaborators
    • Privacy Notice
    • Contact Us
  • Support
    • Customer Portal
    • Datasheets
    • Software Installation
    • Contact Support
Simulations Plus Reports Second Quarter FY2016 Financial Results
View More
Simulations Plus Reports Second Quarter FY2016 Financial Results
  • April 13, 2016
  • Press Release

Simulations Plus Reports Second Quarter FY2016 Financial Results

Keywords: financial results, gross profit, net revenues
Division: PBPK

Record second quarter as revenues grow 12.9%, net income up 18%

  • Read More
Simulations Plus Sets Date for 2nd Quarter 2016 Earnings Release and Conference Call
  • April 8, 2016
  • Press Release

Simulations Plus Sets Date for 2nd Quarter 2016 Earnings Release and Conference Call

Keywords: earnings, investor relations
Division: PBPK

Conference Call to be on Wednesday, April 13, at 4:15 PM ET

  • Read More
Simulations Plus Signs 5-year Consulting Agreement with Major Research Foundation
  • April 6, 2016
  • Press Release

Simulations Plus Signs 5-year Consulting Agreement with Major Research Foundation

Keywords: cloud-based software platform, eradication of underserved diseases, funded research, pharmacometric analyses
Software: KIWI™
Division: Clinical Pharmacology and Pharmacometrics (CPP)

Project provides ~$4.7 million over 5 years to implement a platform for global teams engaged in model-based drug development

  • Read More
Simulations Plus Releases KIWI Version 1.5
  • March 15, 2016
  • Press Release

Simulations Plus Releases KIWI Version 1.5

Keywords: private cloud-based platform
Software: KIWI™
Division: Clinical Pharmacology and Pharmacometrics (CPP), PBPK

A new modeling visualization experience

  • Read More
Simulations Plus Reports Record Preliminary Revenues for Second Quarter FY2016
  • March 10, 2016
  • Press Release

Simulations Plus Reports Record Preliminary Revenues for Second Quarter FY2016

Keywords: preliminary revenues
Division: PBPK
  • Read More
Simulations Plus to Present at Source Capital Group’s 2016 Disruptive Growth & Healthcare Conference
  • January 26, 2016
  • Press Release

Simulations Plus to Present at Source Capital Group’s 2016 Disruptive Growth & Healthcare Conference

Keywords: Disruptive Growth & Healthcare Conference, investor relations
Division: PBPK
  • Read More
Simulations Plus Announces Quarterly Cash Dividend of $0.05 Per Share
  • January 19, 2016
  • Press Release

Simulations Plus Announces Quarterly Cash Dividend of $0.05 Per Share

Keywords: quarterly cash dividend
Division: PBPK
  • Read More
Simulations Plus Reports First Quarter FY2016 Financial Results
  • January 14, 2016
  • Press Release

Simulations Plus Reports First Quarter FY2016 Financial Results

Keywords: financial results, gross profit, net revenues
Division: PBPK

Consolidated net revenues up 18.4%; net income increased 109%

  • Read More
Simulations Plus Sets Date for 1st Quarter 2016 Earnings Release and Conference Call
  • January 8, 2016
  • Press Release

Simulations Plus Sets Date for 1st Quarter 2016 Earnings Release and Conference Call

Keywords: earnings, investor relations
Division: PBPK

Conference Call to be on Thursday, January 14, at 4:15 PM ET

  • Read More
Simulations Plus Reports Record Preliminary Revenues for First Quarter FY2016
  • December 10, 2015
  • Press Release

Simulations Plus Reports Record Preliminary Revenues for First Quarter FY2016

Keywords: preliminary revenues
Division: PBPK
  • Read More
Simulations Plus to Present at Two Upcoming Investor Conferences
  • November 24, 2015
  • Press Release

Simulations Plus to Present at Two Upcoming Investor Conferences

Keywords: Benchmark MicroCap Discovery Conference, investor relations, LD Micro Conference
Division: PBPK

Management to Present at LD Micro Conference in Los Angeles on December 2, and to Attend One-on-One Meetings at the Benchmark MicroCap Discovery Conference in Chicago on December 10

  • Read More
Simulations Plus Reports FY2015 and Fourth Quarter FY2015 Financial Results
  • November 18, 2015
  • Press Release

Simulations Plus Reports FY2015 and Fourth Quarter FY2015 Financial Results

Keywords: financial results, gross profit, net revenues
Division: PBPK

Full Fiscal Year Pharmaceutical Software and Services Up 59.8%; Earnings per share $0.23 cents up $0.05 cents (22.4%) over prior year

  • Read More
Simulations Plus Sets Date for 4th Quarter and Fiscal Year 2015 Earnings Release and Conference Call
  • November 16, 2015
  • Press Release

Simulations Plus Sets Date for 4th Quarter and Fiscal Year 2015 Earnings Release and Conference Call

Keywords: earnings, investor relations
Division: PBPK

Conference Call to be on Wednesday, November 18, 2015, at 4:15 P.M. EST

  • Read More
Simulations Plus Announces Quarterly Cash Dividend of $0.05 Per Share
  • October 28, 2015
  • Press Release

Simulations Plus Announces Quarterly Cash Dividend of $0.05 Per Share

Keywords: quarterly cash dividend
Division: PBPK
  • Read More
Simulations Plus to Launch Major New Software Product
  • October 15, 2015
  • Press Release

Simulations Plus to Launch Major New Software Product

Keywords: compartmental analysis (CA), data management, nca, noncompartmental analysis (NCA)
Software: PKPlus™
Division: PBPK

PKPlus™ Will Provide Analysis Capability Required for Regulatory Submissions

  • Read More
FDA’s Office of New Drug Products Places Order for 50 Additional Licenses to GastroPlus™
  • September 17, 2015
  • Press Release

FDA’s Office of New Drug Products Places Order for 50 Additional Licenses to GastroPlus™

Keywords: FDA Office of Generic Drugs, U.S. FDA
Software: GastroPlus®
Division: PBPK

Additional Licenses Required to Meet Increasing Number of Submissions Utilizing GastroPlus

  • Read More
Simulations Plus Reports Preliminary Revenues for Fourth Quarter and Fiscal Year 2015
  • September 10, 2015
  • Press Release

Simulations Plus Reports Preliminary Revenues for Fourth Quarter and Fiscal Year 2015

Keywords: preliminary revenues
Division: PBPK

Company Reports Record Fourth-Quarter and Full-Year Revenues

  • Read More
Simulations Plus Awarded New Cooperative Agreement with FDA
  • September 3, 2015
  • Press Release

Simulations Plus Awarded New Cooperative Agreement with FDA

Keywords: long-acting injectable microspheres, PBPK simulation, U.S. FDA
Software: GastroPlus®
Division: PBPK

Project to Support Enhancements to Company’s Industry-Leading GastroPlus™ Software

  • Read More
Simulations Plus Reports Third Quarter FY2015 Financial Results
  • July 13, 2015
  • Press Release

Simulations Plus Reports Third Quarter FY2015 Financial Results

Keywords: financial results, gross profit, net revenues
Division: PBPK

Revenues up 58.9%, Net Income up 41.7%
Board declares dividend of $0.05/share

  • Read More
Simulations Plus Sets Date for 3rd Quarter 2015 Earnings Release and Conference Call
  • July 8, 2015
  • Press Release

Simulations Plus Sets Date for 3rd Quarter 2015 Earnings Release and Conference Call

Keywords: earnings, investor relations
Division: PBPK

Conference call to be on Monday, July 13, 2015, at 4:15 p.m. EDT

  • Read More
  • «
  • 1
  • 2
  • …
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • …
  • 27
  • 28
  • »
Ready to get started?

Sign-up for a free evaluation or schedule a meeting with one of our experts!

Questions? Email info@simulations-plus.com

Discuss my project needs with an expert
Schedule a software demo
Join our newsletter
Software
  • GastroPlus®
  • MonolixSuite™
  • ADMET Predictor®
  • DILIsym®
  • DDDPlus™
  • NAFLDsym®
  • MembranePlus™
  • OBESITYsym™
  • PKanalix®
  • Simulx®
  • IPFsym®
  • ILDsym®
  • MITOsym®
  • QSP Software
  • Pro-ficiency
  • Panorama KOL Insights Engine
  • MedChem Designer™
Services
  • Early Drug Discovery
  • Physiologically Based Pharmacokinetics (PBPK)
  • Quantitative Systems Pharmacology (QSP)
  • Clinical Pharmacology & Pharmacometrics (CPP)
  • Adaptive Learning & Insights (ALI)
  • Medical Communications Services
  • Concierge
  • Training and Workshops
Resource Center
  • Blog
  • Journal Articles
  • Flyers
  • Posters
  • Presentations
  • Press Releases
  • Videos
  • White Papers
  • Webinars
Investors
  • Board of Directors
  • Environmental, Social and Governance (ESG)
  • Latest Presentations
  • Press Releases
  • SEC Filings
  • Shareholder Information
  • Corporate Development Initiative
About
  • Simulations Plus
  • Contact
  • Careers
  • Leadership
  • Partners and Collaborators
  • Privacy Notice
  • Cookie Notice
  • Vision, Mission & Values
  • FCOI Policy
Support
  • Customer Portal
  • Datasheets
  • Software Installation
  • Contact Support
Simulations Plus
  • GastroPlus
  • Copyright © 2025 Simulations Plus. All Rights Reserved.
    • Privacy Notice
    • Sitemap
    • Terms of Use
    • Cookie Settings
This website uses cookies
We use cookies to enhance your browsing experience and analyze our traffic. To learn more about our use of cookies and other tracking technologies, please see our Cookie Notice and our Privacy Notice. By clicking “Accept All,” you consent to such use by us of cookies and other tracking technologies. To learn more about your privacy rights and our personal data practices, please see our Privacy Notice.
Accept All Reject AllCookie Settings
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. For more information on use of cookies or similar tracking technologies on our website: View our Cookie Notice. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
Save & Accept